Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MPLKIP | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | CTB-50L17.10 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | TMUB2 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | HACE1 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | MEGF6 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | ACVR1 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | NDC80 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | ZNF286A | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | TEX22 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | RFC5 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |